Sanguine Biosciences Inc., a biotech startup, has raised an undisclosed amount of seed financing from INVENT Ventures and Heliant Ventures. The company is focused on engaging research subjects through social media and non-profit advocacy, and helping schedule blood draws, which are then processed into DNA, RNA, cells, plasma, and serum.
